English  |  正體中文  |  简体中文  |  總筆數 :0  
造訪人次 :  52985968    線上人數 :  712
教育部委託研究計畫      計畫執行:國立臺灣大學圖書館
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
關於TAIR

瀏覽

消息

著作權

相關連結

"hung c h"的相關文件

回到依作者瀏覽
依題名排序 依日期排序

顯示項目 81-90 / 292 (共30頁)
<< < 4 5 6 7 8 9 10 11 12 13 > >>
每頁顯示[10|25|50]項目

機構 日期 題名 作者
臺大學術典藏 2021-09-04T05:16:16Z Factors associated with treatment failure of direct-acting antivirals for chronic hepatitis C: A real-world nationwide hepatitis C virus registry programme in Taiwan Chen C.-Y.; Huang C.-F.; Cheng P.-N.; Tseng K.-C.; Lo C.-C.; Kuo H.-T.; Huang Y.-H.; Tai C.-M.; Peng C.-Y.; Bair M.-J.; Chen C.-H.; Yeh M.-L.; Lin C.-L.; Lin C.-Y.; Lee P.-L.; Chong L.-W.; Hung C.-H.; Huang J.-F.; Yang C.-C.; Hu J.-T.; Lin C.-W.; Chen C.-T.; Wang C.-C.; Su W.-W.; Hsieh T.-Y.; Lin C.-L.; Tsai W.-L.; Lee T.-H.; Chen G.-Y.; Wang S.-J.; Chang C.-C.; Mo L.-R.; Yang S.-S.; Wu W.-C.; Huang C.-S.; Hsiung C.-K.; Kao C.-N.; Tsai P.-C.; Liu C.-H.; Lee M.-H.; Liu C.-J.; Dai C.-Y.; JIA-HORNG KAO; Chuang W.-L.; Lin H.-C.; Yu M.-L.
臺大學術典藏 2021-08-31T06:29:48Z Safety and efficacy of tigatuzumab plus sorafenib as first-line therapy in subjects with advanced hepatocellular carcinoma: A phase 2 randomized study ANN-LII CHENG; Kang Y.-K.; He A.R.; Lim H.Y.; Ryoo B.-Y.; Hung C.-H.; Sheen I.-S.; Izumi N.; Austin T.; Wang Q.; Greenberg J.; Shiratori S.; Beckman R.A.; Kudo M.
臺大學術典藏 2021-08-05T02:36:53Z 3D modeling of the ground deformation along the fault rupture and its impact on engineering structures: Insights from the 1999 Chi-Chi earthquake, Shigang District, Taiwan Lin M.-L;Lin C.-H;Li C.-H;Liu C.-Y;Hung C.-H.; Lin M.-L; Lin C.-H; Li C.-H; Liu C.-Y; Hung C.-H.; MING-LANG LIN
臺大學術典藏 2021-08-05T02:36:53Z 3D sandbox and numerical modeling of coseismic surface rupture induced by oblique-slip faulting and its interaction with embedded shallow foundation Liu C.-Y;Li C.-H;Chan P.-C;Hung C.-H;Lin M.-L.; Liu C.-Y; Li C.-H; Chan P.-C; Hung C.-H; Lin M.-L.; MING-LANG LIN
臺大學術典藏 2021-07-03T03:34:39Z Long-term effect of interferon plus ribavirin on hepatitis B surface antigen seroclearance in patients dually infected with hepatitis B and C viruses Yeh M.-L.; Hung C.-H.; Huang J.-F.; Liu C.-J.; Lee C.-M.; Dai C.-Y.; Wang J.-H.; Lin Z.-Y.; Lu S.-N.; Hu T.-H.; Yu M.-L.; Kao J.-H.; Chuang W.-L.; PEI-JER CHEN; Chen D.-S.
臺大學術典藏 2021-07-03T03:33:34Z Efficacy and safety of 12 weeks of daclatasvir, asunaprevir plus ribavirin for HCV genotype-1b infection without NS5A resistance-associated substitutions Yu M.-L.;Hung C.-H.;Huang Y.-H.;Peng C.-Y.;Lin C.-Y.;Cheng P.-N.;Chien R.-N.;Hsu S.-J.;Liu C.-H.;Huang C.-F.;Su C.-W.;Huang J.-F.;Liu C.-J.;Kao J.-H.;Chuang W.-L.;Pei-Jer Chen;Chen D.-S.; Yu M.-L.; Hung C.-H.; Huang Y.-H.; Peng C.-Y.; Lin C.-Y.; Cheng P.-N.; Chien R.-N.; Hsu S.-J.; Liu C.-H.; Huang C.-F.; Su C.-W.; Huang J.-F.; Liu C.-J.; Kao J.-H.; Chuang W.-L.; PEI-JER CHEN; Chen D.-S.
臺大學術典藏 2021-07-03T03:33:25Z 2020 Taiwan consensus statement on the management of hepatitis C: part (I) general population Yu M.-L.; PEI-JER CHEN; Dai C.-Y.; Hu T.-H.; Huang C.-F.; Huang Y.-H.; Hung C.-H.; Lin C.-Y.; Liu C.-H.; Liu C.-J.; Peng C.-Y.; Lin H.-C.; Kao J.-H.; Chuang W.-L.
臺大學術典藏 2021-07-03T03:33:23Z 2020 Taiwan consensus statement on the management of hepatitis C: Part (II) special populations Yu M.-L.; PEI-JER CHEN; Dai C.-Y.; Hu T.-H.; Huang C.-F.; Huang Y.-H.; Hung C.-H.; Lin C.-Y.; Liu C.-H.; Liu C.-J.; Peng C.-Y.; Lin H.-C.; Kao J.-H.; Chuang W.-L.
臺大學術典藏 2021-07-02T03:41:40Z Young children with beh?et disease have more intestinal involvement Hung C.-H.; Lee J.-H.; Chen S.-T.; Yang Y.-H.; Lin Y.-T.; Wang L.-C.; Yu H.-H.; BOR-LUEN CHIANG
臺大學術典藏 2021-06-04T06:23:14Z Carboxylesterase 2 Is a Fatty Acid Ethyl Ester Synthase Tseng Y.-W.; Lin C.-Y.; Tsai C.-L.; Chou T.-Y.; Hung C.-H.; CHING-HUA KUO; Lai S.-C.; Tzeng Y.-J.

顯示項目 81-90 / 292 (共30頁)
<< < 4 5 6 7 8 9 10 11 12 13 > >>
每頁顯示[10|25|50]項目